Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TH-302
TH-302
Encouraging Initial Data From Ongoing Phase 1/2 Trial of TH-302 Plus Bortezomib (Velcade(R)) Plus Dexamethasone ("TBorD") in Patients With Relapsed/Refractory Multiple Myeloma Presented at ASH Annual Meeting
Yahoo/MarketWired
Sun, 12/7/14 - 09:09 am
TH-302
Threshold Pharmaceuticals
Multiple Myeloma
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
Sat, 10/4/14 - 10:12 am
TH-302
Threshold Pharmaceuticals
glioblastoma
brain cancer
Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer
Seeking Alpha
Tue, 07/8/14 - 07:52 am
Threshold Pharmaceuticals
non-small cell lung cancer
TH-302
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Is Threshold on the Threshold of Something Big?
Motley Fool
Fri, 11/16/12 - 10:34 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
What's Left For Threshold? Not Much
Seeking Alpha
Wed, 10/24/12 - 12:00 pm
Threshold Pharmaceuticals
TH-302
Threshold announces preliminary data from TH-302 study
Yahoo/Fly on the Wall
Mon, 10/1/12 - 10:38 am
Threshold Pharmaceuticals
TH-302
glioblastoma
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Yahoo/MarketWire
Sun, 09/30/12 - 10:33 am
glioblastoma
bevacizumab
TH-302
Threshold Pharmaceuticals
Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk
TheStreet.com
Mon, 09/17/12 - 11:01 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
2 Drug Combination Stocks Targeting Leukemia
Seeking Alpha
Wed, 05/23/12 - 12:04 pm
leukemia
Threshold Pharmaceuticals
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
TH-302
Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
Seeking Alpha
Sat, 05/12/12 - 11:19 am
Threshold Pharmaceuticals
TH-302
cancer
Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer
Seeking Alpha
Sat, 04/28/12 - 12:43 pm
TH-302
pancreatic cancer
Threshold Pharmaceuticals
Threshold’s cancer drug gets Orphan Drug designation
Proactive Investors
Sat, 03/17/12 - 11:23 am
Threshold Pharmaceuticals
TH-302
sarcoma
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Mon, 03/5/12 - 11:08 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
Amgen
Array Biopharma
Micromet
Merck
Pharmacyclics
Threshold Pharmaceuticals: Understanding The Recent Data
Seeking Alpha
Wed, 02/29/12 - 11:07 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
Threshold Pharma's TH-302 for pancreatic cancer shows positive Phase 2b results
Yahoo/Fly on the Wall
Tue, 02/21/12 - 09:02 am
Threshold Pharmaceuticals
pancreatic cancer
TH-302
Threshold Pharmaceuticals: Up 150% In 4 Months With Room To Grow
Seeking Alpha
Tue, 02/7/12 - 04:41 pm
Threshold Pharmaceuticals
TH-302
hypoxia
pancreatic cancer
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Sat, 02/4/12 - 05:01 pm
Threshold Pharmaceuticals
Merck KGaA
TH-302
sarcoma
pancreatic cancer
Threshold Pharma announces clinical trial results of Phase 1 TH-302 study
Yahoo/Fly on the Wall
Wed, 12/14/11 - 11:18 am
Threshold Pharmaceuticals
leukemia
TH-302
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer